UK puts £100 million into an AI Biosecurity Lab, and OpenAI and Anthropic add model credits

Most of the company money arrives as model credits, and Google DeepMind has only promised to try.

By Think Facility · October 24, 2026 · UK AI safety

Britain is setting up an AI Biosecurity Lab to spot biological threats early and speed up work on vaccines and treatments. The Cabinet Office announced it on October 24, 2026, with £100 million of government money.

OpenAI and Anthropic are adding up to £200 million between them. Most of it's model credits, so don't picture a pile of cash. Google DeepMind and Basecamp Research, a London company, have signed on as research partners.

Funding: £100 million of government funding
OpenAI: £100 million in compute and model credits
Anthropic: up to £100 million in model credits
Partners: Google DeepMind and Basecamp Research
First jobs: early detection, and vaccines, treatments and other medical countermeasures

Who's giving what

OpenAI's £100 million comes as compute and model credits. It also gets the lab trusted access to its most capable relevant models, through something OpenAI calls the Rosalind Biodefense program. Anthropic's figure is a ceiling: up to £100 million in credits, plus model access and its own technical support.

A man with short dark hair and round glasses, in a gray suit, white shirt and dark tie, standing in front of a Welsh flag and a Union flag — Kanishka Narayan, the UK's AI minister, in a 2025 government portrait. Photo: Department for Science, Innovation and Technology, CC BY 4.0, via Wikimedia Commons

Google DeepMind's part is a bit looser. Its scientists will work with the lab on research, and the company "will look to provide trusted access" to frontier Gemini and specialized science models. That's a promise to try, nothing firmer yet.

So who runs it? Nobody named so far. It'll be an independent non-profit, modeled loosely on the AI Security Institute (the government body that tests frontier models before release), and it's meant to move at the speed of a startup. A scientific advisory committee comes later, with details "in due course." There's no director, site or start date in the release.

Why a government wants this

The Cabinet Office makes the case both ways at once. AI can speed up research and help find new medicines. It can also put dangerous biology within reach of more people.

increasingly capable AI systems also create new biological risks and could lower barriers to harmful activity

From Introducing the AI Biosecurity Lab

Kanishka Narayan, the AI minister, called the lab a major new global institution. He said it in the Treasury's release on the wider AI package, where he also argued Britain can't rely entirely on technology built overseas.

Twelve days earlier he'd told the labs not to release a system whose risks they can't control. Now two of those labs are paying into a British safety body. I think that's the bigger shift of the two.

The bigger package around it

The lab is the main part of a £165 million National AI Biosecurity Initiative. The other £65 million goes to bio surveillance and to medical countermeasures for priority pathogens. And that whole initiative is just one line in an AI package the Treasury put out the same day, ahead of Chancellor John Healey's Budget.

AI Biosecurity Initiative: £165m
AI Security Institute: an additional £120 million
NERV Centre: a new £70 million centre for cyber vulnerabilities
National Cyber Shield: £60 million

Several groups quoted in that release welcomed it. CEPI, the vaccine coalition, put the risk most plainly.

Rapid advances in AI are creating new risks related to the design and modification of pathogens, increasing the potential for both accidental and deliberate harm.

From Chancellor unveils Britain’s ambitious plan for AI

Imperial College London's president, Hugh Brady, went further. He said a biological threat is now both likelier and potentially worse, whether it starts in nature or in someone's lab.

What it means for outbreaks and medicines

Outside the AI business, the lab's real test is the next outbreak. Britain's own report on its biosecurity strategy, covering July 2025 to July 2026, shows why. On May 17 the World Health Organization declared the Bundibugyo strain of Ebola, spreading in the Democratic Republic of the Congo and Uganda, a public health emergency of international concern. In June the UK put up to £5 million into treatments and rapid tests for it.

That report also says a University of Cambridge team developed the first entirely AI-designed vaccine this year. It's the kind of work the new lab is meant to speed up. Granted, that vaccine came out of a university (the new lab has no vaccine projects of its own yet).

17 May 2026WHO declares the Bundibugyo emergency
12 October 2026Narayan tells labs not to release uncontrollable systems
24 October 2026AI Biosecurity Lab announced

Then there's regulation. The lab will work with the Medicines and Healthcare products Regulatory Agency on health emergencies, and on how AI-designed medicines should be regulated. Which rules? The release doesn't say.

As money goes, £100 million is modest here. The same strategy report lists over £1.83 billion for a Network of National Biosecurity Centres (£1 billion of that at Weybridge, £580 million at Dstl Porton Down). The UK Health Security Agency, the Animal and Plant Health Agency and Dstl are the partners named in the initiative.

Britain's 2023 Biological Security Strategy set the target: a UK resilient to a spectrum of biological threats by 2030. Next comes the advisory committee, and the Cabinet Office says details will follow.